Cicor Technologies (CICN) Investor presentation summary

Market positioning and business focus

• Ranked fourth among EMS companies in Europe, with a strong presence in industrial, healthcare technology, and aerospace & defence sectors, addressing a €21.4 billion market with a 5.6% CAGR forecast for 2024-2027.

• 2025 sales expected at CHF 616.5 million, up 28.2%, with an EBITDA margin of 10.5% and free cash flow of CHF 49.1 million before acquisitions.

• Key verticals: industrial (38% of 2025 sales), aerospace & defence (26%), and healthcare technology (19%).

• Expanded manufacturing and engineering footprint to 7 markets, accessing over 70% of European electronics OEMs.

Strategic acquisitions and consolidation

• Completed acquisitions in 2025 include Éolane (France), Mercury Systems (Switzerland), MADES (Spain), Profectus Solutions (Germany), and Valtronic sites (Morocco, USA), strengthening positions in A&D, healthcare, and industrial sectors.

• Proven M&A track record, driving industry consolidation and expanding into France, Spain, and the US.

• Integration of five acquired companies is a key priority for 2026.

Financial performance and growth

• Adjusted EBITDA doubled and adjusted net profit nearly tripled from 2022 to 2025; 2025 adjusted EBITDA reached CHF 64.6 million.

• 2025 net sales grew 28.2% to CHF 616.5 million, with a book-to-bill ratio of 1.05 and free cash flow conversion at 87%.

• Adjusted earnings per share for 2025 at CHF 7.45, with market capitalization rising 113% year-over-year to CHF 558.8 million.

• Leverage at year-end 2025 was 1.10, providing financial flexibility for further acquisitions.